Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to FOLFIRI
Related studies linked through entity extraction aliases.
EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Inavolisib When Administered in Combination With Bevacizumab and FOLFOX or FOLFIRI as First Line Therapy in Participants With Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Status
- RECRUITING
- Phase
- PHASE1
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of PM8002 in Combination With Chemotherapy in Patients With NEN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of DKN-01 in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Switch Maintenance in Pancreatic
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2